Avita Medical | 1811094D - Gross Profit On Sales

Stock Price
1.34
Daily Change
-0.01 -0.37%
Monthly
-4.30%
Yearly
-49.24%
Q3 Forecast
1.33

Avita Medical reported AUD16.13M in Gross Profit on Sales for its fiscal semester ending in December of 2024.



Financials
Stock Price AUD
Assets AUD 79.71M
Cash and Equivalent AUD 14.05M
Cost of Sales AUD 2.28M
Current Assets AUD 57M
Current Liabilities AUD 20.16M
Debt AUD 45.99M
EBIT AUD -10.27M
EBITDA AUD -9.86M
Employees AUD 87
EPS Earnings Per Share AUD -0.21
Equity Capital and Reserves AUD 4.5M
Gross Profit on Sales AUD 16.13M
Interest Expense on Debt AUD 1.35M
Loan Capital AUD 42.25M
Market Capitalization AUD 175.79M
Net Income AUD -11.59M
Operating Expenses AUD 28.36M
Operating Profit AUD -9.96M
Pre-Tax Profit AUD -11.57M
Sales Revenues AUD 18.41M
Selling and Administration Expenses AUD 21.23M
Stock AUD 7.27M
Trade Creditors AUD 6.29M
Trade Debtors AUD 11.96M

Gross Profit On Sales Change Date
Adcock Ingram Holdings ZAR 1.54B 73.26M Dec/2024
Celltrion KRW 442.87B 100.93B Mar/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Cochlear AUD 881.7M 14.5M Dec/2024
CSL USD 4.28B 939M Dec/2024
Cspc Pharmaceutical CNY 4.71B 391.66M Mar/2025
Dianthus Therapeutics USD 193K 970K Jun/2025
Divis Laboratories Ltd 14.54B 1.5B Jun/2025
Kangmei Pharma CNY 223.73M 38.54M Mar/2025
Knight Therapeutics CAD 45.02M 2.32M Sep/2024
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Malin Corporation EUR 3.8M 2.6M Dec/2020
Mayne Pharma AUD 115.99M 63.1M Jun/2024
Medical Developments International AUD 14.72M 1.36M Dec/2024
Nanosonics AUD 73.44M 38.94M Dec/2024
Organigram Holdings CAD 26.15M 25.1M Jun/2025
Pacific Edge NZD 283K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 414.94K 4.82M Dec/2024
Pharma Mar EUR 53.61M 18.15M Jun/2025
Polynovo AUD 23.26M 22.74M Jun/2024
PYC Therapeutics AUD 6.58M 2.13M Jun/2024
Qiagen NV USD 334.29M 25.6M Jun/2025
Ramsay Health Care AUD 6.32B 20.5M Dec/2024
ResMed USD 829.44M 78.16M Jun/2025
Sartorius EUR 416.2M 14.8M Jun/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024
Tilray USD 61.22M 1.51M Nov/2024
Zz Pientze Pharmaceu 296.13M 1.1B Jun/2025